Exclusive: DeepMind’s Demis Hassabis unveils his vision for Isomorphic and AI’s future in biotech
While Demis Hassabis is best known for steering Alphabet’s research efforts in artificial intelligence, the 47-year-old is simultaneously leading a secretive biotech startup looking to bring about an AI revolution in drug discovery.
Hassabis is the CEO of Google DeepMind as well as Isomorphic Labs, an Alphabet-backed company founded in 2021 to take DeepMind’s AI research in biology further into the drug industry. DeepMind has won a myriad of awards for AlphaFold2, its AI system that predicts protein structures and was published in 2021. Headquartered in London, Isomorphic has shared few details about what it’s working on in its roughly two years of existence.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.